Crossmedika

Crossmedika is an Italian healthcare company that specializes in the distribution and marketing of pharmaceutical products and medical devices, with a core focus on hyaluronic acid-based treatments. A subsidiary of Fidia Farmaceutici, the company is a key player in the therapeutic areas of joint health and aesthetic medicine. Its product portfolio includes prominent brands like Hyalubrix and Hyalgan, which are indicated for the treatment of osteoarthritis and joint-related pain. Crossmedika also provides solutions for tissue repair and dermatology, utilizing advanced viscosupplementation technology. The company operates primarily in the Italian market while benefiting from the global research and manufacturing infrastructure of its parent organization.